Students urged to get H1N1 shot before spring break

by Tina Redlup on March 9, 2010

Cdc

With spring break coming up and large numbers of students expected to travel both domestically and internationally, getting vaccinated against 2009 H1N1 influenza is especially important.

Supreme Court to decide if vaccine makers can be sued

by Tina Redlup on March 8, 2010

Cdc

WASHINGTON — The Supreme Court announced March 8 that it would decide whether a federal law protects vaccine manufacturers from lawsuits in state court seeking damages for alleged design defects.

Pneumococcal conjugate vaccine beneficial in HIV, report says

by Tina Redlup on March 6, 2010

Hiv

HIV

A seven-valent pneumococcal conjugate vaccine can protect adults with HIV against recurrent pneumococcal infection, according to research published in the March 4 issue of the New England Journal of Medicine.

CDC awards contracts to evaluate effectiveness of H1N1 vaccine

by Tina Redlup on March 6, 2010

Flu_vaccine

The Centers for Disease Control and Prevention has awarded Abt Associates two new contracts to evaluate the effectiveness of the H1N1 vaccine among health care workers and children younger than 18, the company announced March 5.

CDC monitors malaria cases in Haiti

by Tina Redlup on March 5, 2010

Malaria

The U.S. Centers for Disease Control and Prevention has received reports of several cases of malaria in Haiti since a 7.0 magnitude earthquake struck the country Jan. 12.

'Painless' vaccine needle invented in Japan

by Tina Redlup on March 4, 2010

Flu_vaccine

Kanji Takada, a professor of pharmacokinetics, has developed a round vaccine "chip" measuring 1.5 centimeters in diameter that contains as many as 300 micro needles.

Advisory committee silent on high-dose flu vaccine for elderly

by Tina Redlup on March 3, 2010

Cdc

The U.S. Advisory Committee on Immunization Practices last week heard a report about the high-dose influenza vaccine that was recently approved for people 65 and older but voiced no preference for its use in that age group.

Scientists use Olympics to study spread of infectious diseases

by Tina Redlup on March 2, 2010

Vancouver-olympics

As an international crowd of athletes and supporters gathered en masse in Vancouver, some scientists used the Olympics as their virtual test tube to find out how to prevent the outbreak of diseases spread by air travel.

Vaccine advice outweighs fear of autism, study finds

by Tina Redlup on March 1, 2010

Cdc

CHICAGO — One in four U.S. parents believes some vaccines cause autism in healthy children, but even many of those worried about vaccine risks think their children should be vaccinated, The Associated Press reported March 1.

WHO says pandemic at less severe end of spectrum: WHO

by Tina Redlup on February 27, 2010

Who

World Health Organization

GENEVA — The current H1N1 swine flu pandemic is relatively less severe than some other influenza outbreaks, the World Health Organization said Feb. 24

Dutch find no link between infant deaths, vaccine

by Tina Redlup on February 25, 2010

Pfizer

AMSTERDAM — The Dutch health authority RIVM said Feb. 23 the deaths of three infants last year were not related to a vaccine produced by U.S. pharmaceutical company Wyeth, now part of Pfizer.

Texas university gets $40 million grant to make tobacco-based vaccine

by Tina Redlup on February 25, 2010

Dod

The Texas A&M University System and a Texas company have been awarded a $40 million grant from the U.S. Department of Defense to develop vaccines made from tobacco rather than the antiquated egg-based technology.

Young kids should get new Prevnar, U.S. experts say

by Tina Redlup on February 24, 2010

Pneumococcal

Pneumococcal

Children younger than 5 who already got four doses of Pfizer Inc.'s Prevnar 13 vaccine should get a fifth booster dose of the new version that covers more strains of pneumonia-causing bacteria.

South African officials say H1N1 outbreak threatens World Cup

by Tina Redlup on February 22, 2010

World-cup

CAPE TOWN, South Africa — South Africa faces a possible health crisis if an H1N1 flu outbreak strikes during the soccer World Cup this year, the country’s health minister told parliament Feb. 15, Reuters reported.

AIDS vaccine effects may wear off, researchers say

by Tina Redlup on February 19, 2010

Niaid_logo

National Institute of Allergy and Infectious Diseases

WASHINGTON — An AIDS vaccine that appears to have worked at least partly in Thailand may only temporarily protect patients, with the effects starting to wane after a year or so, researchers reported Feb. 18.

Study shows how viruses altered evolution

by Tina Redlup on February 18, 2010

Poli-di-milano

Politecnico di Milano

LONDON — Italian scientists said Feb. 19 that they had found evidence of how viruses helped change the course of human evolution and said their discovery could help in the design of better drugs and vaccines.

Measles outbreak spreading in South Africa

by Tina Redlup on February 16, 2010

Who

World Health Organization

The cause of a measles outbreak sweeping South Africa has not as yet been determined, but initial suspicions point to religious objections and unfounded fears that immunizations against the disease increase the risk of autism in children.

WHO to decide whether worst over in H1N1 pandemic

by Tina Redlup on February 15, 2010

Who

World Health Organization

GENEVA — The World Health Organization will convene its emergency committee later this month to examine whether the H1N1 flu pandemic has peaked, its top influenza expert said Feb. 11.

Voluntary system of H1N1 vaccinations works, research shows

by Tina Redlup on February 12, 2010

Vaccine

Social interaction between neighbors, work colleagues and other communities and social groups makes voluntary vaccination programs for epidemics such as H1N1 flu, SARS or avian flu a surprisingly effective method of disease control.

CDC answers questions about vaccine selection for 2010-11 flu season

by Tina Redlup on February 11, 2010

Cdc

The Centers for Disease Control and Prevention recently addressed questions about the vaccine for the 2010-11 flu season on its Web site.

New York City urges some to get mumps vaccine

by Tina Redlup on February 10, 2010

Mumps

Mumps

NEW YORK — New York City health officials are encouraging young adults, especially males, in the Jewish communities in Brooklyn to get vaccinated for mumps, UPI reported Feb. 9.

Nearly half of Americans believe H1N1 outbreak is over, poll finds

by Tina Redlup on February 9, 2010

H1n1

H1N1

BOSTON – The latest poll from researchers at the Harvard School of Public Health shows that 44 percent of Americans believe the H1N1 flu outbreak is over, and levels of concern about getting sick with the virus continue to decline.

Novavax, Rovi end flu vaccine development plan

by Tina Redlup on February 8, 2010

Novavax-vlp-vaccine

Novavax's viruslike particle vaccines

TEL AVIV, Israel — Novavax Inc. announced Feb. 8 that it ended talks aimed at a collaboration with Rovi Pharmaceuticals of Madrid to develop Novavax's viruslike particle vaccines against influenza in Spain.

Researchers uncover genome of malaria parasite

by Tina Redlup on February 5, 2010

Malaria

Malaria

Research done at Singapore's Nanyang Technological University's School of Biological Sciences could lead to the development of more potent drugs or a vaccine for malaria, ScienceDaily reported Feb. 5.

Progress is slow on moving surplus H1N1 flu vaccine to countries in need

by Tina Redlup on February 4, 2010

Who

World Health Organization

There is now so much unused H1N1 pandemic flu vaccine in the world that rich nations, including the United States, are trying to get rid of their surpluses.

Biotech companies find progress in vaccine market

by Tina Redlup on February 3, 2010

Flu_vaccine

When it comes to vaccines, everyone now wants to get in on the action.

Some viruses use fats to penetrate a cell

by Tina Redlup on February 2, 2010

Sv40

SV40

SV40 viruses use an amazing means of communication, in order to be able to penetrate into a cell: fats, whose structure must fit like a key in a lock, ScienceDaily reported Jan. 29.

MSF says it is responding to rise in malaria infections in Burundi

by Tina Redlup on February 1, 2010

Malaria

Malaria

Médecins Sans Frontières teams in Burundi's Kayanza province assessing and treating patients in the midst of a rise in the incidence of malaria, the organization also known as Doctors Without Borders reported Jan. 29.

Partnership to support vaccine formulation across PATH projects

by Tina Redlup on February 1, 2010

Pneumococcal

Pneumococcal

PATH, an international nonprofit global health organization, recently signed an agreement with the University of Kansas Center for Research to support the advancement of vaccine candidates across its vaccine development portfolio.

New vaccine method is cheaper more effective, researchers say

by Tina Redlup on January 29, 2010

Nih

Traditional vaccines can be ineffective and expensive. Now, an interdisciplinary team of Cornell researchers has devised a new way to make vaccines that promises to prevent diseases much more cheaply, the university announced Jan. 25.

New work offers hope for effective salmonella vaccine

by Tina Redlup on January 29, 2010

Salmonella

Salmonella

Research from Malawi, Birmingham and Liverpool has renewed hope that an effective vaccine could be developed against nontyphoidal strains of salmonella.

Open letter to the American people about the H1N1 flu vaccine

by Tina Redlup on January 28, 2010

Flu_vaccine

More than 30 health providers and organizations released an open letter advising people to get vaccinated. Below is the text of that letter.

Vaccine approach extends life of prostate cancer patients, trial shows

by Tina Redlup on January 28, 2010

Prostatecancer

Prostate Cancer Cells

In a newly published clinical trial, patients with metastatic prostate cancer who received a vaccine of harmless poxviruses lived substantially longer than patients who received a placebo vaccine.

Rotavirus vaccine 'could save millions of­­ lives'

by Tina Redlup on January 27, 2010

Rotavirus

Rotavirus

WASHINGTON — A vaccination campaign to combat rotavirus in the world's poorest countries could save the lives of hundreds of thousands of children, according to a pair of studies published this week.

WHO addresses allegations of faking pandemic

by Tina Redlup on January 26, 2010

Who

The World Health Organization released a statement Jan. 22 addressing allegations of a conflict of interest and a fake pandemic meant to aid the pharmaceutical industry.

Gastric ulcer bacteria turn immune defense inward, researchers say

by Tina Redlup on January 25, 2010

Helicobacter

Helicobacter Pylori

Despite a strong response from our immune defense, the body is unable to rid itself of the bacterium Helicobacter pylori.

Venezuela to U.S.: Send Haiti vaccine, not troops

by Tina Redlup on January 25, 2010

Haiti_flag

Venezuelan President Hugo Chavez has called on Washington to send medication to the quake-stricken Haiti rather than troops.

Novartis flu adjuvant boosts wide protection, FDA study says

by Tina Redlup on January 22, 2010

Niaid_logo

National Institute of Allergy and Infectious Diseases

WASHINGTON — A vaccine additive made by Novartis and used in its European influenza shots can boost the body's immune response to a wide range of viruses, U.S. researchers reported Jan. 20 according to Reuters.

Heisman winner urges Ohioans to get vaccines

by Tina Redlup on January 21, 2010

Archie_griffin

Archie Griffin

COLUMBUS, Ohio — The Ohio Department of Health partnered with Archie Griffin, a two-time Heisman Trophy winner and Ohio State University alumnus, to encourage Ohioans to tackle H1N1 by getting a flu vaccine.

Gorillas carry malignant malaria parasite, study reports

by Tina Redlup on January 20, 2010

Malaria

Malaria

The parasite that causes malignant malaria in humans has been detected in gorillas, according to a study co-authored by biologist Francisco Ayala of the University of California, Irvine.

Cervical cancer vaccine will cut cases by two thirds, experts calculate

by Tina Redlup on January 19, 2010

Hpv

HPV

The number of women under 30 diagnosed with cervical cancer will fall nearly two thirds by 2025 thanks to the vaccine against human papillomavirus, researchers say.

1 in 5 Americans got swine flu vaccine, CDC reports

by Tina Redlup on January 18, 2010

Cdc

ATLANTA — About one in five Americans has been vaccinated against H1N1 flu, according to the government's first detailed estimates of vaccination rates against the pandemic, the Washington Post reported Jan. 16.

Poland refuses H1N1 flu vaccines

by Tina Redlup on January 15, 2010

Who

World Health Organization

WARSAW, Poland — The government here refused to import H1N1 flu vaccines amid worldwide warnings of a spreading epidemic.

Singer shows how 'quick and easy' H1N1 vaccination can be

by Tina Redlup on January 14, 2010

Derulo

Jason Derülo

“Whatcha Say” singer Jason Derülo had a stellar 2009 — a No. 1 Billboard Hot 100 single, an opening spot on Lady Gaga's Monster Ball Tour — and he knows that if he wants to step it up in 2010, he's going to have to stay healthy.

Phase II study starts for intranasal, seasonal influenza vaccine deltaFLU

by Tina Redlup on January 13, 2010

H1n1

HiN1

VIENNA — AVIR Green Hills Biotechnology, based in Austria, announced Jan. 13 that it is embarking on the first clinical phase II study for the seasonal vaccine deltaFLU

Hospital workers fired after refusing flu vaccine

by Tina Redlup on January 13, 2010

Flu_vaccine

CHARLESTON, W.Va. — Charleston Area Medical Center plans to terminate two employees for refusing to take a seasonal flu vaccine, the Charleston Daily Mail reported Jan. 13.

Glaxo reduces Germany’s H1N1 vaccine shipment by $193 million

by Tina Redlup on January 12, 2010

Flu_vaccine

LONDON — GlaxoSmithKline Plc agreed to reduce Germany’s order of Pandemrix H1N1 flu vaccine by $193 million on Jan. 12 after health officials decided they need fewer doses, the country’s Health Ministry said.

President, HHS announces national influenza vaccination week

by Tina Redlup on January 12, 2010

Cdc

President Barack Obama, the U.S. Department of Health and Human Services and its Centers for Disease Control and Prevention announced a nationwide effort to encourage H1N1 flu vaccination during National Influenza Vaccination Week from Jan. 10–16.

Cambodia records more cases of malaria and dengue fever in 2009

by Tina Redlup on January 8, 2010

Malaria_mosquito

Malaria

PHNOM PENH, Cambodia — Cambodia has seen a rise in reported cases of dengue fever and malaria in 2009, local media reported Jan. 5, citing health officials here.

Flu vaccine’s effects reduced in arthritis patients treated with rituximab

by Tina Redlup on January 7, 2010

Flu_vaccine

Flu Vaccine

Flu shots do not protect arthritis patients who are being treated with the intravenous drug rituximab, according to a new study by Dutch researchers, The New York Times and Los Angeles Times reported Jan. 7.

CDC addresses safety of thimerosal in vaccines against H1N1 flu

by Tina Redlup on January 7, 2010

H1n1

H1N1

The Centers for Disease Control and Prevention posted this “fact sheet” about thimerosal in H1N1 vaccines on its Web site Jan. 4.

Another study finds no link between vaccine, autism

by Tina Redlup on January 4, 2010

Vaccine

NEW YORK — A new study provides further evidence that the measles-mumps-rubella vaccine is not associated with an increased risk of autism, Reuters Health reported Jan. 4.

CDC Flu Wrap

by Tina Redlup on January 2, 2010

Cdc

The Center for Disease Control has reported only four cases of flu-related pediatric mortality across seven states during the week ending January 2.

Sharks killed for oil used in H1N1 flu vaccine

by Tina Redlup on January 1, 2010

Squalene

Squalene

Vaccines being made to protect people from H1N1 flu may not be so healthy for threatened species of sharks, National Geographic News reported Dec. 29.

Swedish research might point to stomach cancer vaccine

by Tina Redlup on December 31, 2009

Stomach-cancer

Stomach Cancer

GOTHENBURG, Sweden — New research at Sahlgrenska Academy might be an important step toward creating a vaccine against ulcers and stomach cancer, The Local reported Dec. 30.

WHO chief yet to be vaccinated against H1N1

by Tina Redlup on December 28, 2009

Who

World Health Organization

GENEVA — World Health Organization chief Margaret Chan revealed that she has yet to be vaccinated against the H1N1 flu virus, which has killed more than 11,500 people worldwide.

England made progress against tuberculosis, but more needs done, report says

by Tina Redlup on December 26, 2009

Tuberculosis

TB

National Health Service efforts to tackle tuberculosis in England are improving, but worryingly nearly 18 percent TB hot spot areas, and 60 percent of all areas, still don't have a strategy in place to tackle the disease.

FDA approves a high dose flu influenza vaccine intended for seniors

by Tina Redlup on December 24, 2009

Fda-logo

SILVER SPRING, Md. — The U.S. Food and Drug Administration approved Fluzone High-Dose, an inactivated influenza virus vaccine for people ages 65 years and older to prevent disease caused by influenza virus subtypes A and B.

Nasal swine flu vaccine recalled over potency

by Tina Redlup on December 23, 2009

Fda-logo

WASHINGTON -- Drugmaker MedImmune is recalling nearly 5 million doses of H1N1 flu vaccine because the nasal spray appears to lose strength over time, federal health officials announced Dec. 22.

Medicago reports positive trial results for its avian flu pandemic vaccine

by Tina Redlup on December 22, 2009

H5n1

H5N1

QUEBEC CITY — Medicago Inc., a biotechnology company focused on developing vaccines based on proprietary manufacturing technologies and virus-like particles.

Study suggests 1 H1N1 shot may protect kids; CDC disagrees

by Tina Redlup on December 22, 2009

Cdc

Can young children get by with just one dose of the H1N1 swine flu vaccine?

EU agency recommends Novartis meningitis vaccine

by Tina Redlup on December 18, 2009

Fda-logo

ZURICH — Europe's drugs watchdog has recommended approving a meningitis vaccine made by Switzerland's Novartis, according to Reuters.

Sanofi aims to double vaccine sales by 2013

by Tina Redlup on December 17, 2009

H1n1

H1N1

PARIS — French drugmaker Sanofi-Aventis SA aims to double sales at its Sanofi Pasteur vaccines business by 2013, compared to the 2008 level, and reiterated it could make acquisitions in this fast-growing area.

Pneumonia shots not going to all who need them, authorities say

by Tina Redlup on December 16, 2009

Flu_vaccine

Pneumococcal vaccine

While a nationwide push for vaccination against H1N1 and seasonal flu has led to long lines for shots, another vaccine against a common and deadly flu complication — pneumonia — hasn't gotten nearly as much attention.

Vaccination key to stemming rotavirus, experts say

by Tina Redlup on December 14, 2009

Who

World Health Organization

DAKAR, Senegal — Health experts in Africa are calling on governments to vaccinate children against rotavirus, to end an “unacceptable” yet preventable situation in which the virus kills some 1,400 children in developing countries daily

CDC Flu Wrap

by Tina Redlup on December 14, 2009

Cdc

The Centers for Disease Control has reported 16 flu-related deaths among children across nine states during the week ending December 5.

China worries swine flu vaccine campaign faltering

by Tina Redlup on December 11, 2009

H1n1

H1N1

BEIJING (Reuters) - China's vaccination campaign against the H1N1 flu strain is not proceeding as fast as it should be partly because people are needlessly worried about the vaccine’s safety, officials said Dec. 11.

CDC Flu Wrap

by Tina Redlup on December 11, 2009

Cdc

Centers for Disease Control

The Centers for Disease Control has reported only nine cases of flu-related pediatric mortality across seven states during the week ending December 12. This the lowest number reported by the CDC so far this quarter.

Health experts say more funds needed for TB tests, drugs, vaccines

by Tina Redlup on December 10, 2009

Tuberculosis

Tuberculosis

CANCUN, Mexico — Health experts called for more research funding to develop better diagnostic tests, vaccines and drugs for tuberculosis, which killed 1.8 million people around the world last year.

Stanford fellow argues for better vaccines for the next pandemic

by Tina Redlup on December 9, 2009

Cdc

The H1N1 swine flu has sickened at least 22 million and killed almost 4,000 in the United States since April, according to the Centers for Disease Control and Prevention.

Medical countermeasure development should be priority, BARDA director says

by Tina Redlup on December 7, 2009

Flu_vaccine

Flu Vaccine

WASHINGTON — Congress, the Obama administration and taxpayers need to accept that drugmakers are not going to pursue discovery and development of emergency medical countermeasures out of the kindness of their hearts.

Measles deaths drop by 78 percent but resurgence feared

by Tina Redlup on December 3, 2009

Measles

Measles

LONDON -- Global deaths from measles fell by 78 percent between 2000 and 2008 thanks largely to mass childhood vaccination campaigns, but experts say death rates may rise again if complacency allows immunization efforts to lag.

CDC: Flu activity eases, but child deaths still climb

by Tina Redlup on December 2, 2009

H1n1

H1N1

The number of states with widespread pandemic flu activity dropped for the third week in a row, but the virus continued to take a heavy toll on children, with at least 27 more pediatric deaths reported the week of Nov 15 to 21.

Bavarian Nordic will file for market approval for Imvamune in Canada

by Tina Redlup on December 2, 2009

Hedegaard_anders

Anders Hedegaard

KVISTGARD, Denmark — Bavarian Nordic A/S announced Nov. 30 that it expects to file a new drug submission for its third-generation smallpox vaccine, Imvamune with Health Canada in the second half of 2010.

GSK files Rotarix for prevention of rotavirus in Japan

by Tina Redlup on November 30, 2009

Who

GlaxoSmithKline announced Nov. 30 that it has filed its vaccine for the prevention of rotavirus gastroenteritis (approved as Rotarix in several countries outside of Japan).

New case of avian flu confirmed in Egypt

by Tina Redlup on November 27, 2009

Avian_flu

Avian flu

The Ministry of Health of Egypt has reported a new confirmed human case of avian influenza A (H5N1), the World Health Organization said Nov. 27.

Drug-resistant H1N1 no major change in virus, WHO says

by Tina Redlup on November 26, 2009

H1n1

H1N1

GENEVA — Tamiflu resistance in some H1N1 patients with badly weakened immune systems does not seem to reflect a major change in the virus' susceptibility to the frontline drug, the World Health Organization said Nov. 26.

World AIDS Day set for Dec. 1

by Tina Redlup on November 26, 2009

Hiv

HIV

World AIDS Day on Dec. 1 is intended to draw together people from around the world to raise awareness about HIV/AIDS and demonstrate international solidarity in the face of the pandemic, according to the World Health Organization.

CDC confirms 4 new cases of Tamiflu-resistant H1N1

by Tina Redlup on November 24, 2009

Cdc

DURHAM, N.C. -- Tests have confirmed that samples from four patients with H1N1 influenza were found to be resistant to oseltamivir, known by the brand name Tamiflu.

GAVI Alliance says immunizations reduced child deaths in Vietnam

by Tina Redlup on November 23, 2009

Gavi_logo

HANOI, Vietnam — Through its commitment to immunization and other child health interventions, Vietnam has drastically reduced its child deaths, the GAVI Alliance announced Nov. 20 during its partner forum.

Fighting tuberculosis should be priority, Fauci says

by Tina Redlup on November 20, 2009

Fauci_anthony

Dr. Anthony Fauci

Dr. Anthony Fauci wrote this commentary, posted Nov. 17, for msnbc.com. He is director of the National Institute of Allergy and Infectious Diseases in Bethesda, Md.

Panenza, Sanofi Pasteur’s H1N1 vaccine, approved in France

by Tina Redlup on November 18, 2009

H1n1

H1N1

LYON, France — Sanofi Pasteur, the vaccines division of the sanofi-aventis Group announced that the French drug agency Afssaps has granted marketing authorization in France for Panenza, its non-adjuvanted Influenza H1N1 2009 monovalent vaccine.

U.S. reports largest mumps outbreak in 3 years

by Tina Redlup on November 16, 2009

Mumps

Mumps Virus

ATLANTA — U.S. health officials say the largest U.S. outbreak of mumps in three years is occurring in New York and New Jersey, The Associated Press reports.

Rare Ebola-like virus poses new threat to U.S. troops in Afghanistan

by Tina Redlup on November 11, 2009

Ebola

Ebola

KANDAHAR, Afghanistan — U.S. military officials sent a medical team to a remote outpost in southern Afghanistan this week to take blood samples from members of an Army unit after a soldier in the unit died from an Ebola-like virus.

CDC Flu Wrap

by Tina Redlup on November 9, 2009

Cdc

The Center for Disease Control has reported 35 flu-related pediatric deaths that occurred in 17 states during the week ending November 9. The previous week only reported 18 deaths in nine states.

U.S. includes BioThrax, Anthrax Immune Globulin in PREP Act

by Tina Redlup on October 9, 2008

Anthrax2

Anthrax

Emergent BioSolutions Inc. announced that two medical countermeasures included in its anthrax franchise have been included as covered countermeasures under the Public Readiness and Emergency Preparedness Act.

Emergent BioSolutions submits proposal to develop new anthrax vaccine

by Tina Redlup on July 31, 2008

Anthrax2

Anthrax

ROCKVILLE, Md. — Emergent BioSolutions Inc. announced July 31, 2008, that it has submitted a proposal in response to a request by the U.S. Department of Health and Human Services for a recombinant protective antigen anthrax vaccine (rPA).

Emergent BioSolutions acquires monoclonal anthrax product candidate

by Tina Redlup on March 6, 2008

Anthrax2

Anthrax

ROCKVILLE, Md. —Emergent BioSolutions Inc. announced that on March 6, 2008, it completed the acquisition of a group of anthrax monoclonal antibodies from AVANIR Pharmaceuticals, including Avanir’s lead product candidate, AVP-21D9.

Emergent BioSolutions’ CEO to ring stock exchange’s opening bell

by Tina Redlup on November 22, 2006

El-hibri_fuad

Fuad El-Hibri

GAITHERSBURG, Md. — Emergent BioSolutions Inc. announced that it would celebrate its recently completed initial public offering with the ringing of the opening bell of the New York Stock Exchange by chairman and CEO Fuad El-Hibri on Nov. 22, 2006.

NIAID gives 2 grants for development of anthrax immune globulin therapeutic

by Tina Redlup on August 31, 2006

Anthrax2

Anthrax

Emergent BioSolutions announced that it has been awarded two grants from the National Institute of Allergy and Infectious Diseases totaling $3.8 million to support the development of the anthrax immune globulin (AIG) therapeutic product.

Former DHHS secretary joins board of directors of Emergent BioSolutions

by Tina Redlup on June 21, 2006

Dept-hhs

GAITHERSBURG, Md. — Emergent BioSolutions Inc. announced June 21, 2006, that a former secretary of the U.S. Department of Health and Human Services has been named to its board of directors.